Form 4: Alignment Healthcare Exec Sells Shares
Insider Transaction Report
Joseph S. Konowiecki, EVP of Corporate Affairs at Alignment Healthcare, Inc., reported a sale of 25,000 common shares.
Summary
- Joseph S. Konowiecki, Executive Vice President of Corporate Affairs and a Director at Alignment Healthcare, Inc., has reported a transaction involving the sale of 25,000 shares of common stock.
- The transaction occurred on June 18, 2026, with the shares sold at a price of $22 per share.
- Following this transaction, Konowiecki beneficially owns 1,153,816 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider stock sale under a pre-arranged plan, which is common for personal financial planning and does not inherently signal company performance issues.
Negatives
- Executive Vice President and Director Joseph S. Konowiecki sold 25,000 shares of common stock.
Future Outlook
The filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While a sale by a high-ranking executive can sometimes signal a lack of confidence, it can also be part of pre-arranged trading plans (like the Rule 10b5-1 plan mentioned) for personal financial management, and does not necessarily indicate a negative outlook for the company.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rule 10b5-1 Plan Adoption | A Rule 10b5-1 trading plan was adopted on March 4, 2026, for the purchase or sale of equity securities. | 03/04/2026 | Provides an affirmative defense against insider trading allegations for transactions executed under the plan. |
Stakeholder Impact
- Shareholders may observe this transaction, but the existence of a Rule 10b5-1 plan suggests it is part of a pre-determined strategy rather than a reaction to new information.
Key Dates
| Date | Description |
|---|---|
| 03/04/2026 | Date of adoption of Rule 10b5-1 plan |
| 06/18/2026 | Transaction Date and Earliest Transaction Date |
Keywords
Alignment Healthcare, ALHC, Form 4, Insider Trading, Stock Sale, Joseph S. Konowiecki, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.